Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes

Biswarathan Ramani(University of California, San Francisco), Henry L. Paulson(University of Michigan)

Human Molecular Genetics

June 7, 2017

10.1093/hmg/ddx224

Cited by 55

Related Papers

Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7

|Progress in Neurobiology|2013|360

Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3

|The EMBO Journal|2009|170

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice

|Annals of Neurology|2018|156

Degeneration of the Cerebellum in <scp>H</scp>untington's Disease (<scp>HD</scp>): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process

|Brain Pathology|2012|147

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (<scp>SCA27B</scp>)

|Annals of Neurology|2024|30